Profil
Colin Walsh is currently Director at Ceptur Therapeutics, Inc., Managing Director-Life Sciences Investing at The Goldman Sachs Group, Inc. since 2023, Director at Vicebio Ltd. since 2024, Independent Director at Attovia Therapeutics, Inc. since 2024, and Board Member at Element Science, Inc. since 2019.
Former roles include Independent Director at Elevation Oncology, Inc. from 2019 to 2023, Vice President at NanoDimension, Inc., Partner at Qiming US Ventures Management, LLC from 2020 to 2023, Senior Associate at NanoDimension Management Ltd., Principal at Precision NanoSystems, Inc., and Board Member at Korro Bio, Inc. (United States) from 2020 to 2023.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.
Aktive Positionen von Colin Walsh
| Unternehmen | Position | Beginn |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01.09.2023 |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic medicines | Direktor/Vorstandsmitglied | - |
Element Science, Inc.
Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable cardioverter defibrillators | Direktor/Vorstandsmitglied | 01.08.2019 |
Vicebio Ltd.
Vicebio Ltd. BiotechnologyHealth Technology Develops next-generation respiratory virus vaccines using molecular clamp technology | Direktor/Vorstandsmitglied | 01.09.2024 |
Ehemalige bekannte Positionen von Colin Walsh
| Unternehmen | Position | Ende |
|---|---|---|
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Investor | 31.10.2023 |
| ELEN ONCO | Direktor/Vorstandsmitglied | 21.09.2023 |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Direktor/Vorstandsmitglied | 01.09.2023 |
Precision NanoSystems, Inc.
Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures equipment related to testing electricity and electrical signals | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Colin Walsh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
Element Science, Inc.
Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable cardioverter defibrillators | Electronic Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management invests in companies located in the United States and Europe. The firm focuses on the technology sector. It provides for early and later stage companies. | Finance |
NanoDimension, Inc.
NanoDimension, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Precision NanoSystems, Inc.
Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures equipment related to testing electricity and electrical signals | Electronic Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
Elevation Oncology, Inc.
Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Vicebio Ltd.
Vicebio Ltd. BiotechnologyHealth Technology Develops next-generation respiratory virus vaccines using molecular clamp technology | Health Technology |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic medicines | Health Technology |
University of Massachusetts Amherst
University of Massachusetts Amherst Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
















